Showing results (161-170 of 478) with videos related to
Sort By:
Pageof 48
Open Heart|February 6, 2016
Prevalence and prognostic impact of kidney disease on heart failure patientsIda Löfman, Karolina Szummer, Inger Hagerman, et al.Scandinavian Cardiovascular Journal : SCJ|September 1, 2016
Cardiac resynchronization therapy: results, challenges and perspectives for the futureMarcus Ståhlberg, Frieder Braunschweig, Fredrik Gadler, et al.Circulation. Heart Failure|February 7, 2013
Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort studyLars H Lund, Bodil Svennblad, Håkan Melhus, et al.Heart Failure Reviews|August 30, 2025
Pharmacological options to relieve congestion in acute heart failureChris J Kapelios, Ali Vazir, Lars H Lund, et al.Artificial Organs|November 8, 2018
VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome PredictorsThomas Fux, Manne Holm, Matthias Corbascio, et al.The Journal of Thoracic and Cardiovascular Surgery|October 23, 2018
Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortalityThomas Fux, Manne Holm, Matthias Corbascio, et al.Clinical Transplantation|April 10, 2020
Induction immunosuppression strategies and long-term outcomes after heart transplantationShahab Nozohoor, Josef Stehlik, Lars H Lund, et al.Upsala Journal of Medical Sciences|August 11, 2018
The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failureGianluigi Savarese, Peter Vasko, Åsa Jonsson, et al.Heliyon|March 20, 2023
A machine learning model for prediction of 30-day primary graft failure after heart transplantationBjörn Linse, Mattias Ohlsson, Joseph Stehlik, et al.Cardiovascular Research|August 14, 2021
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanismsGianluigi Savarese, Javed Butler, Lars H Lund, et al.Pageof 48